Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 170

    1.

    Effects of intensive insulin therapy alone and with added pioglitazone on renal salt/water balance and fluid compartment shifts in type 2 diabetes.

    Mudaliar S, Chang AR, Aroda VR, Chao E, Burke P, Baxi S, Griver KA, O'Connor DT, Henry RR.

    Diabetes Obes Metab. 2009 Nov 2. [Epub ahead of print]PMID: 19889003 [PubMed - as supplied by publisher]Related articles

    2.

    Pharmacotherapy of hyperglycemia.

    Kulasa KM, Henry RR.

    Expert Opin Pharmacother. 2009 Oct;10(15):2415-32. Review.PMID: 19743938 [PubMed - indexed for MEDLINE]Related articles

    3.

    Actos Now for the prevention of diabetes (ACT NOW) study.

    Defronzo RA, Banerji M, Bray GA, Buchanan TA, Clement S, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner R, Reaven PD, Schwenke D, Stentz FB, Tripathy D.

    BMC Endocr Disord. 2009 Jul 29;9:17.PMID: 19640291 [PubMed - in process]Related articlesFree article

    4.

    Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans.

    Phillips SA, Kung J, Ciaraldi TP, Choe C, Christiansen L, Mudaliar S, Henry RR.

    Am J Physiol Endocrinol Metab. 2009 Sep;297(3):E767-73. Epub 2009 Jul 21.PMID: 19622782 [PubMed - indexed for MEDLINE]Related articles

    5.

    Incretin therapies: effects beyond glycemic control.

    Mudaliar S, Henry RR.

    Eur J Intern Med. 2009 Jul;20 Suppl 2:S319-28. Epub 2009 Jun 21. Review.PMID: 19580951 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study.

    Henry RR, Lincoff AM, Mudaliar S, Rabbia M, Chognot C, Herz M.

    Lancet. 2009 Jul 11;374(9684):126-35. Epub 2009 Jun 8.PMID: 19515415 [PubMed - indexed for MEDLINE]Related articles

    7.

    GSK-3beta and control of glucose metabolism and insulin action in human skeletal muscle.

    Ciaraldi TP, Carter L, Mudaliar S, Henry RR.

    Mol Cell Endocrinol. 2009 Jun 6. [Epub ahead of print]PMID: 19505532 [PubMed - as supplied by publisher]Related articles

    8.

    Incretin therapies: effects beyond glycemic control.

    Mudaliar S, Henry RR.

    Am J Med. 2009 Jun;122(6 Suppl):S25-36. Review.PMID: 19464425 [PubMed - indexed for MEDLINE]Related articles

    9.

    The role of incretins in cardiovascular control.

    Mafong DD, Henry RR.

    Curr Hypertens Rep. 2009 Feb;11(1):18-22.PMID: 19146796 [PubMed - indexed for MEDLINE]Related articles

    10.

    Myotoxic reactions to lipid-lowering therapy are associated with altered oxidation of fatty acids.

    Phillips PS, Ciaraldi TP, Kim DL, Verity MA, Wolfson T, Henry RR; Scripps Mercy Clinical Research Center.

    Endocrine. 2009 Feb;35(1):38-46. Epub 2008 Dec 3.PMID: 19051066 [PubMed - indexed for MEDLINE]Related articles

    11.

    Response of adiponectin and its receptors to changes in metabolic state after gastric bypass surgery: dissociation between adipose tissue expression and circulating levels.

    Savu MK, Phillips SA, Oh DK, Park K, Gerlan C, Ciaraldi TP, Henry RR.

    Surg Obes Relat Dis. 2009 Mar-Apr;5(2):172-80. Epub 2008 Aug 22.PMID: 18996753 [PubMed - indexed for MEDLINE]Related articles

    12.

    Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial.

    Aroda VR, Ciaraldi TP, Burke P, Mudaliar S, Clopton P, Phillips S, Chang RJ, Henry RR.

    J Clin Endocrinol Metab. 2009 Feb;94(2):469-76. Epub 2008 Nov 4.PMID: 18984667 [PubMed - indexed for MEDLINE]Related articles

    13.

    Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance.

    Ciaraldi TP, Aroda V, Mudaliar S, Chang RJ, Henry RR.

    J Clin Endocrinol Metab. 2009 Jan;94(1):157-63. Epub 2008 Oct 14.PMID: 18854391 [PubMed - indexed for MEDLINE]Related articles

    14.

    Is adiposopathy (sick fat) an endocrine disease?

    Bays HE, González-Campoy JM, Henry RR, Bergman DA, Kitabchi AE, Schorr AB, Rodbard HW; Adiposopathy Working Group.

    Int J Clin Pract. 2008 Oct;62(10):1474-83. Epub 2008 Aug 4. Review.PMID: 18681905 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue.

    Phillips SA, Ciaraldi TP, Oh DK, Savu MK, Henry RR.

    Am J Physiol Endocrinol Metab. 2008 Oct;295(4):E842-50. Epub 2008 Jul 29.PMID: 18664597 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Evolving concepts of type 2 diabetes management with oral medications: new approaches to an old disease.

    Henry RR.

    Curr Med Res Opin. 2008 Aug;24(8):2189-202. Epub 2008 Jun 20. Review.PMID: 18573228 [PubMed - indexed for MEDLINE]Related articles

    17.

    Exenatide as a treatment for diabetes and obesity: implications for cardiovascular risk reduction.

    Mafong DD, Henry RR.

    Curr Atheroscler Rep. 2008 Feb;10(1):55-60. Review.PMID: 18366986 [PubMed - indexed for MEDLINE]Related articles

    18.

    Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.

    Bays HE, González-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB, Rodbard HW, Henry RR.

    Expert Rev Cardiovasc Ther. 2008 Mar;6(3):343-68. Review.PMID: 18327995 [PubMed - indexed for MEDLINE]Related articles

    19.

    Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action.

    Aroda V, Ciaraldi TP, Chang SA, Dahan MH, Chang RJ, Henry RR.

    Fertil Steril. 2008 May;89(5):1200-8. Epub 2007 Aug 13.PMID: 17706206 [PubMed - indexed for MEDLINE]Related articles

    20.

    Inhaled insulin in patients with asthma and chronic obstructive pulmonary disease.

    Mudaliar S, Henry RR.

    Diabetes Technol Ther. 2007 Jun;9 Suppl 1:S83-92.PMID: 17563308 [PubMed - indexed for MEDLINE]Related articles

    21.

    Role of glycogen synthase kinase-3 alpha in insulin action in cultured human skeletal muscle cells.

    Ciaraldi TP, Nikoulina SE, Bandukwala RA, Carter L, Henry RR.

    Endocrinology. 2007 Sep;148(9):4393-9. Epub 2007 Jun 14.PMID: 17569761 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Adiponectin in health and disease.

    Oh DK, Ciaraldi T, Henry RR.

    Diabetes Obes Metab. 2007 May;9(3):282-9. Review.PMID: 17391153 [PubMed - indexed for MEDLINE]Related articles

    23.

    Electron paramagnetic spectroscopic evidence of exercise-induced free radical accumulation in human skeletal muscle.

    Bailey DM, Lawrenson L, McEneny J, Young IS, James PE, Jackson SK, Henry RR, Mathieu-Costello O, McCord JM, Richardson RS.

    Free Radic Res. 2007 Feb;41(2):182-90.PMID: 17364944 [PubMed - indexed for MEDLINE]Related articles

    24.

    Cardiometabolic risk modification: current trends and emerging therapies.

    Lillo JL, Bray G, Woods SC, Henry RR, Hadley RD.

    JAAPA. 2006 Dec;Suppl Cardiometabolic:3-14; quiz 15-6. No abstract available. PMID: 17354517 [PubMed - indexed for MEDLINE]Related articles

    25.

    Impaired fasting glucose and impaired glucose tolerance: implications for care.

    Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B; American Diabetes Association.

    Diabetes Care. 2007 Mar;30(3):753-9. Review. No abstract available. PMID: 17327355 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.

    Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB.

    N Engl J Med. 2006 Jun 15;354(24):2552-63.PMID: 16775236 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Tissue-specific expression and regulation of GSK-3 in human skeletal muscle and adipose tissue.

    Ciaraldi TP, Oh DK, Christiansen L, Nikoulina SE, Kong AP, Baxi S, Mudaliar S, Henry RR.

    Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E891-8. Epub 2006 Jun 6.PMID: 16757548 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin.

    Riddle MC, Henry RR, Poon TH, Zhang B, Mac SM, Holcombe JH, Kim DD, Maggs DG.

    Diabetes Metab Res Rev. 2006 Nov-Dec;22(6):483-91.PMID: 16634116 [PubMed - indexed for MEDLINE]Related articles

    29.

    Diabetes treatments have differential effects on nontraditional cardiovascular risk factors.

    Fonseca VA, Theuma P, Mudaliar S, Leissinger CA, Clejan S, Henry RR.

    J Diabetes Complications. 2006 Jan-Feb;20(1):14-20.PMID: 16389162 [PubMed - indexed for MEDLINE]Related articles

    30.

    Effect of a high-carbohydrate versus a high--cis-monounsaturated fat diet on blood pressure in patients with type 2 diabetes.

    Shah M, Adams-Huet B, Bantle JP, Henry RR, Griver KA, Raatz SK, Brinkley LJ, Reaven GM, Garg A.

    Diabetes Care. 2005 Nov;28(11):2607-12.PMID: 16249527 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Adipocyte differentiation-related protein in human skeletal muscle: relationship to insulin sensitivity.

    Phillips SA, Choe CC, Ciaraldi TP, Greenberg AS, Kong AP, Baxi SC, Christiansen L, Mudaliar SR, Henry RR.

    Obes Res. 2005 Aug;13(8):1321-9.PMID: 16129713 [PubMed - indexed for MEDLINE]Related articles

    32.

    Gastric cancer risk in a Mexican population: role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and -10 genes.

    Sicinschi LA, Lopez-Carrillo L, Camargo MC, Correa P, Sierra RA, Henry RR, Chen J, Zabaleta J, Piazuelo MB, Schneider BG.

    Int J Cancer. 2006 Feb 1;118(3):649-57.PMID: 16114018 [PubMed - indexed for MEDLINE]Related articles

    33.

    Effects of the rapid-acting insulin analog glulisine on cultured human skeletal muscle cells: comparisons with insulin and insulin-like growth factor I.

    Ciaraldi TP, Phillips SA, Carter L, Aroda V, Mudaliar S, Henry RR.

    J Clin Endocrinol Metab. 2005 Oct;90(10):5551-8. Epub 2005 Jul 19.PMID: 16030168 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Pancreastatin: multiple actions on human intermediary metabolism in vivo, variation in disease, and naturally occurring functional genetic polymorphism.

    O'Connor DT, Cadman PE, Smiley C, Salem RM, Rao F, Smith J, Funk SD, Mahata SK, Mahata M, Wen G, Taupenot L, Gonzalez-Yanes C, Harper KL, Henry RR, Sanchez-Margalet V.

    J Clin Endocrinol Metab. 2005 Sep;90(9):5414-25. Epub 2005 Jun 14.PMID: 15956083 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists.

    Cha BS, Ciaraldi TP, Park KS, Carter L, Mudaliar SR, Henry RR.

    Am J Physiol Endocrinol Metab. 2005 Jul;289(1):E151-9. Epub 2005 Feb 22.PMID: 15727952 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes.

    Buse JB, Henry RR, Han J, Kim DD, Fineman MS, Baron AD; Exenatide-113 Clinical Study Group.

    Diabetes Care. 2004 Nov;27(11):2628-35.PMID: 15504997 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Skeletal muscle GLUT1 transporter protein expression and basal leg glucose uptake are reduced in type 2 diabetes.

    Ciaraldi TP, Mudaliar S, Barzin A, Macievic JA, Edelman SV, Park KS, Henry RR.

    J Clin Endocrinol Metab. 2005 Jan;90(1):352-8. Epub 2004 Oct 13.PMID: 15483099 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Diabetes and obesity: medical diseases, surgical cure?

    Aroda VR, Savu MK, Henry RR.

    Curr Diab Rep. 2004 Oct;4(5):317-8. No abstract available. PMID: 15461894 [PubMed - indexed for MEDLINE]Related articles

    39.

    Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus.

    Bhalla MA, Chiang A, Epshteyn VA, Kazanegra R, Bhalla V, Clopton P, Krishnaswamy P, Morrison LK, Chiu A, Gardetto N, Mudaliar S, Edelman SV, Henry RR, Maisel AS.

    J Am Coll Cardiol. 2004 Sep 1;44(5):1047-52.PMID: 15337217 [PubMed - indexed for MEDLINE]Related articles

    40.

    Glitazones and the management of insulin resistance: what they do and how might they be used.

    Einhorn D, Aroda VR, Henry RR.

    Endocrinol Metab Clin North Am. 2004 Sep;33(3):595-616, vii-viii. Review.PMID: 15262299 [PubMed - indexed for MEDLINE]Related articles

    41.

    Combination therapy for type 2 diabetes.

    Mudaliar S, Henry RR.

    Endocr Pract. 1999 Jul-Aug;5(4):208-19.PMID: 15251678 [PubMed]Related articles

    42.

    Hyperglycemia with antipsychotic treatment.

    Sathyaprakash R, Henry RR.

    Curr Diab Rep. 2004 Feb;4(1):41-5. Review.PMID: 14764279 [PubMed - indexed for MEDLINE]Related articles

    43.

    Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp.

    Sowell M, Mukhopadhyay N, Cavazzoni P, Carlson C, Mudaliar S, Chinnapongse S, Ray A, Davis T, Breier A, Henry RR, Dananberg J.

    J Clin Endocrinol Metab. 2003 Dec;88(12):5875-80.PMID: 14671184 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes.

    Grotz VL, Henry RR, McGill JB, Prince MJ, Shamoon H, Trout JR, Pi-Sunyer FX.

    J Am Diet Assoc. 2003 Dec;103(12):1607-12.PMID: 14647086 [PubMed - indexed for MEDLINE]Related articles

    45.

    Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications.

    Mudaliar S, Chang AR, Henry RR.

    Endocr Pract. 2003 Sep-Oct;9(5):406-16. Review.PMID: 14583425 [PubMed - indexed for MEDLINE]Related articles

    46.

    Insulin resistance: from predisposing factor to therapeutic target in type 2 diabetes.

    Henry RR.

    Clin Ther. 2003;25 Suppl B:B47-63. Review.PMID: 14553866 [PubMed - indexed for MEDLINE]Related articles

    47.

    Young and elderly type 2 diabetic patients inhaling insulin with the AERx insulin diabetes management system: a pharmacokinetic and pharmacodynamic comparison.

    Henry RR, Mudaliar S, Chu N, Kim D, Armstrong D, Davis TT, An B, Reinhardt RR.

    J Clin Pharmacol. 2003 Nov;43(11):1228-34.PMID: 14551177 [PubMed - indexed for MEDLINE]Related articles

    48.

    Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction.

    Kim YB, Kotani K, Ciaraldi TP, Henry RR, Kahn BB.

    Diabetes. 2003 Aug;52(8):1935-42.PMID: 12882908 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Adiponectin: more than just another fat cell hormone?

    Chandran M, Phillips SA, Ciaraldi T, Henry RR.

    Diabetes Care. 2003 Aug;26(8):2442-50. Review. No abstract available. PMID: 12882876 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Regulation of skeletal muscle morphology in type 2 diabetic subjects by troglitazone and metformin: relationship to glucose disposal.

    Mathieu-Costello O, Kong A, Ciaraldi TP, Cui L, Ju Y, Chu N, Kim D, Mudaliar S, Henry RR.

    Metabolism. 2003 May;52(5):540-6.PMID: 12759881 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...